1.
Journal of Gynecologic Oncology
;
: e88-2018.
Artigo
em Inglês
| WPRIM
| ID: wpr-718156
2.
Palliative Care Research
;
: 570-574, 2013.
Artigo
em Japonês
| WPRIM
| ID: wpr-374803
RESUMO
<b>Introduction</b>: Tramadol (TRM) has been included as a weak opioid at the second step of the WHO analgesic ladder and has been widely used in palliative medicine. Here we report a case of amelioration of cancer pain by TRM therapy in a female patient with myasthenia gravis (MG). <b>Case</b>:The patient was a 70’s woman who was diagnosed with advanced endometrial carcinoma and suffered from chest pain caused by chest metastasis. 25 mg of a TRM capsule was orally administered three times a day. The dose was increased to 50 mg twice a day. It was resulted in sound pain relief with transient muscle weakness but without a myasthenic crisis.